-
Tomohiro Kinoshita
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan, Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital, Nagoya, Japan,
-
Takashi Watanabe
Department of Hematology, National Cancer Center Hospital, Tokyo, Japan,
-
Kuniaki Itoh
Division of Oncology and Hematology, National Cancer Center Hospital East, Kashiwa, Japan,
-
Kenichi Yoshimura
Department of Biostatistics, Medical Center for Translational and Clinical Research, Hiroshima University Hospital, Hiroshima, Japan,
-
Kensei Tobinai
Department of Hematology, National Cancer Center Hospital, Tokyo, Japan,
-
Michinori Ogura
Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital, Nagoya, Japan,
-
Motoko Yamaguchi
Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Japan,
-
Mitsutoshi Kurosawa
Department of Hematology, National Hospital Organization, Hokkaido Cancer Center, Sapporo, Japan,
-
Yoshitaka Imaizumi
Nagasaki University Hospital, Nagasaki, Japan,
-
Shuichi Ota
Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan,
-
Harumi Kaba
Data Management Division, Clinical Research Support Office, National Cancer Center, Tokyo, Japan,
-
Kiyoshi Mukai
Pathology Division, National Cancer Center Research Institute, Tokyo, Japan,
-
Shigeo Nakamura
Department of Pathology and Clinical Laboratories, Nagoya University Hospital, Nagoya, Japan,
-
Koichi Ohshima
First Department of Pathology, Kurume University School of Medicine, Kurume, Japan,
-
Tomomitsu Hotta
Department of Hematology and Oncology, National Hospital Organization Nagoya Medical Center, Nagoya, Japan,
-
Kunihiro Tsukasaki
Department of Hematology, International Medical Center, Saitama Medical University, Saitama, Japan,
-
Hirokazu Nagai
Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan,
-
Masanori Shimoyama
National Cancer Center Hospital, Tokyo, Japan
